{
    "body": "How can the fetal Rhesus be determined with non-invasive testing?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25380024", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24778561", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21686347", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10985940", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24204719", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22386678", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26152007", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26140187", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24786470", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21075065", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18751991", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26259290", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21576416", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20938838", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23072857", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15980640", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21244652", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20482298", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18945714"
    ], 
    "ideal_answer": [
        "The detection of fetal RhD status can be achieved with the non-invasive method of assessing free fetal DNA in the maternal blood."
    ], 
    "exact_answer": [
        "free fetal DNA from maternal cirulcation"
    ], 
    "type": "factoid", 
    "id": "571366ba1174fb1755000005", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 71, 
            "text": "Determination of fetal rhesus d status by maternal plasma DNA analysis.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24778561", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 232, 
            "text": "In this study, we assessed the feasibility of fetal RhD genotyping by analysis of cell-free fetal DNA(cffDNA) extracted from plasma samples of Rhesus (Rh) D-negative pregnant women by using real-time polymerase chain reaction (PCR).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24778561", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 979, 
            "offsetInEndSection": 1172, 
            "text": "Performing real-time PCR on cffDNA showed accurate, efficient and reliable results, allowing rapid and high throughput non invasive determination of fetal sex and RhD status in clinical samples", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24778561", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 68, 
            "text": "Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26152007", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 138, 
            "offsetInEndSection": 311, 
            "text": "The aim of this study is to determine fetal RhD status in the Rh incompatible pregnancies with an non-invasive technique; free fetal DNA isolation from maternal circulation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26152007", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1057, 
            "offsetInEndSection": 1405, 
            "text": " The detection of fetal RhD status by using a non-invasive method from maternal circulation was found to be possible. Assessing fetal RhD status non-invasively by using free fetal DNA in maternal blood will be cost-efficient, avoiding unnecessary indirect Coombs test and unnecessary Rhogam applications that is used in RH incompatible pregnancies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26152007", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1133, 
            "offsetInEndSection": 1411, 
            "text": "Fruitful research efforts have resulted in the clinical implementation of a number of non-invasive prenatal tests based on maternal plasma DNA analysis and included tests for fetal sex assessment, fetal rhesus D blood group genotyping and fetal chromosomal aneuploidy detection.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23072857", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 84, 
            "text": "Non-invasive antenatal diagnosis of fetal rhesus status in an alloimmunised patient.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21686347", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1793, 
            "offsetInEndSection": 2230, 
            "text": "Our subsequent investigations have shown that this elevation in fetal cell traffic may serve as an early marker for those pregnancies at risk for this disorder.A very recent exciting discovery has been that free extracellular fetal DNA can be detected in the plasma and serum of pregnant women, which may permit the rapid and accurate detection of uniquely fetal loci, such as the fetal rhesus D gene in rhesus D negative pregnant women.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10985940", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 168, 
            "text": "Fetal rhesus D (RhD) status determination using circulating cell-free fetal DNA from maternal plasma or serum is now recognized in Europe as a reliable and useful tool.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22386678", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 921, 
            "offsetInEndSection": 1222, 
            "text": "NGS is now sufficiently sensitive to analyze circulating fetal DNA in maternal blood (cell-free fetal DNA, cffDNA), enabling applications such as non invasive diagnosis of fetal sex (and X-linked diseases), fetal rhesus among rhesus-negative women, trisomy and, in the near future, Mendelian mutations", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26259290", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 160, 
            "text": "High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spectrometry", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18751991", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 105, 
            "text": "Non-invasive RNA-based determination of fetal Rhesus D type: a prospective study based on 96 pregnancies.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10519426", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 212, 
            "text": "BACKGROUND: Analysis of cell free fetal (cff) DNA in maternal plasma is used routinely for non invasive prenatal diagnosis (NIPD) of fetal sex determination, fetal rhesus D status and some single gene disorders. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23024794", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 862, 
            "offsetInEndSection": 1140, 
            "text": "Fruitful research efforts have resulted in the clinical implementation of a number of non-invasive prenatal tests based on maternal plasma DNA analysis and included tests for fetal sex assessment, fetal rhesus D blood group genotyping and fetal chromosomal aneuploidy detection.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23072857", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 323, 
            "text": " Non-invasive prenatal diagnosis and testing by analysis of cell-free DNA in the maternal circulation is a rapidly evolving field. Current clinical applications include fetal sex determination, fetal rhesus D determination, the diagnosis of some single gene disorders, and a highly accurate screening test for aneuploidies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24786470", 
            "endSection": "abstract"
        }
    ]
}